Only Adymite
Medical Device
First Adymite
Artificial Disc
Born from
Diamonds
Request More Info
15
Jan

Dymicron Announces First Patient Enrolled in Triadyme-C IDE Clinical Trial

0

Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced the successful enrollment and treatment of the first patient in its Triadyme®-C Investigational Device Exemption (IDE) clinical trial. This milestone marks the initiation of a U.S. clinical study evaluating the safety and effectiveness of the Triadyme-C cervical artificial disc.

About the author

Recent Comments

    Categories

    Stay Connected for the Latest from Dymicron

    Sign up to discover the latest news about Dymicron and our proprietary polycrystalline diamond technology–Adymite. Adymite is redefining performance and reliability in spinal disc replacement, including delivering unmatched durability and excellent long-term outcomes for patients.